Xantphos

CAS No. 161265-03-8

Xantphos( —— )

Catalog No. M33641 CAS No. 161265-03-8

Xantphos, a ligand in the coupling reaction of Buchwald, Suzuki and others, is a metal chelating ligand that can be used to catalyze the reaction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Xantphos
  • Note
    Research use only, not for human use.
  • Brief Description
    Xantphos, a ligand in the coupling reaction of Buchwald, Suzuki and others, is a metal chelating ligand that can be used to catalyze the reaction.
  • Description
    Xantphos, a ligand in the coupling reaction of Buchwald, Suzuki and others, is a metal chelating ligand that can be used to catalyze the reaction.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    161265-03-8
  • Formula Weight
    578.62
  • Molecular Formula
    C39H32OP2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1(C)C2=CC=CC(P(C3=CC=CC=C3)C3=CC=CC=C3)=C2OC2=C(C=CC=C12)P(C1=CC=CC=C1)C1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • EN6

    EN6-mediated ATP6V1A modification decouples the v-ATPase from the Rags, leading to inhibition of mTORC1 signaling.

  • Icosabutate

    Icosabutate (NST-4016) is an orally active derivative of eicosapentaenoic acid that inhibits hepatic inflammation and fibrosis in NASH, improves cardiovascular risk profiles in statin-treated patients with residual hypertriglyceridemia, lowers triglycerides, and may be useful in studies of liver fibrosis and atherosclerosis.

  • CRT-0105950

    CRT-0105950 is a potent LIMK inhibitor with high affinity for both LIMK1 and LIMK2.CRT-0105950 inhibits filamentous cutin phosphorylation and promotes α-microtubulin acetylation in cells.